News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
261,631 Results
Type
Article (12380)
Company Profile (32)
Press Release (249214)
Multimedia
Podcasts (21)
Webinars (3)
Section
Business (76696)
Career Advice (1080)
Deals (14616)
Drug Delivery (39)
Drug Development (35457)
Employer Resources (39)
FDA (6149)
Job Trends (5885)
News (130139)
Policy (9689)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (1)
Academia (785)
Academic (1)
Accelerated approval (22)
Adcomms (17)
Allergies (113)
Alliances (10454)
ALS (111)
Alzheimer's disease (830)
Antibody-drug conjugate (ADC) (299)
Approvals (6616)
Artificial intelligence (341)
Autoimmune disease (207)
Automation (33)
Bankruptcy (97)
Best Places to Work (5208)
BIOSECURE Act (2)
Biosimilars (144)
Biotechnology (22)
Bladder cancer (167)
Brain cancer (41)
Breast cancer (553)
Cancer (3873)
Cardiovascular disease (306)
Career advice (859)
Career pathing (12)
CAR-T (174)
CDC (14)
Celiac Disease (1)
Cell therapy (480)
Cervical cancer (40)
Clinical research (33736)
Collaboration (1100)
Company closure (2)
Compensation (1416)
Complete response letters (27)
COVID-19 (1025)
CRISPR (58)
C-suite (504)
Cystic fibrosis (78)
Data (5515)
Decentralized trials (1)
Denatured (1)
Depression (91)
Dermatology (60)
Diabetes (340)
Diagnostics (2653)
Digital health (26)
Diversity (2)
Diversity, equity & inclusion (7)
Drug discovery (166)
Drug pricing (63)
Drug shortages (12)
Duchenne muscular dystrophy (169)
Earnings (60719)
Editorial (20)
Employer branding (5)
Employer resources (34)
Events (43227)
Executive appointments (540)
FDA (8486)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (7)
Frontotemporal dementia (21)
Funding (909)
Gene editing (123)
Generative AI (19)
Gene therapy (369)
GLP-1 (607)
Government (1478)
Grass and pollen (5)
Guidances (377)
Healthcare (7451)
HIV (62)
Huntington's disease (26)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (65)
Immunology and inflammation (193)
Immuno-oncology (57)
Indications (128)
Infectious disease (1207)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (71)
Intellectual property (98)
Interviews (195)
IPO (9333)
IRA (16)
Job creations (997)
Job search strategy (748)
JPM (19)
Kidney cancer (16)
Labor market (56)
Layoffs (202)
Leadership (16)
Legal (1743)
Liver cancer (58)
Longevity (9)
Lung cancer (547)
Lymphoma (327)
Machine learning (26)
Management (13)
Manufacturing (446)
MASH (137)
Medical device (5449)
Medtech (5513)
Mergers & acquisitions (6097)
Metabolic disorders (918)
mRNA (67)
Multiple sclerosis (113)
NASH (9)
Neurodegenerative disease (232)
Neuropsychiatric disorders (63)
Neuroscience (1675)
NextGen: Class of 2026 (2281)
Non-profit (1502)
Now hiring (24)
Obesity (423)
Opinion (92)
Ovarian cancer (121)
Pain (129)
Pancreatic cancer (159)
Parkinson's disease (198)
Partnered (9)
Patents (199)
Patient recruitment (353)
Peanut (45)
People (10606)
Pharmaceutical (11)
Pharmacy benefit managers (12)
Phase 1 (9345)
Phase 2 (14435)
Phase 3 (12750)
Pipeline (6290)
Policy (64)
Postmarket research (1269)
Preclinical (3233)
Press Release (14)
Prostate cancer (212)
Psychedelics (26)
Radiopharmaceuticals (166)
Rare diseases (626)
Real estate (1185)
Recruiting (17)
Regulatory (9244)
Reports (30)
Research institute (778)
Resumes & cover letters (199)
Rett syndrome (34)
RNA editing (11)
RSV (64)
Schizophrenia (122)
Series A (139)
Series B (113)
Service/supplier (2)
Sickle cell disease (73)
Special edition (15)
Spinal muscular atrophy (65)
Sponsored (18)
Startups (843)
State (1)
Stomach cancer (8)
Supply chain (62)
Tariffs (27)
The Weekly (20)
Vaccines (518)
Venture capital (46)
Weight loss (285)
Women's health (55)
Worklife (5)
Date
Today (102)
Last 7 days (558)
Last 30 days (2355)
Last 365 days (18968)
2026 (7757)
2025 (19424)
2024 (18404)
2023 (17837)
2022 (21574)
2021 (22718)
2020 (20351)
2019 (17973)
2018 (12802)
2017 (12137)
2016 (10411)
2015 (12724)
2014 (9078)
2013 (6615)
2012 (7212)
2011 (7510)
2010 (6715)
Location
Africa (301)
Alabama (34)
Alaska (1)
Arizona (116)
Arkansas (7)
Asia (15773)
Australia (2420)
California (8808)
Canada (2036)
China (848)
Colorado (332)
Connecticut (359)
Delaware (318)
Europe (37281)
Florida (996)
Georgia (209)
Hawaii (3)
Idaho (21)
Illinois (659)
India (44)
Indiana (343)
Iowa (13)
Japan (416)
Kansas (62)
Kentucky (25)
Louisiana (29)
Maine (43)
Maryland (879)
Massachusetts (6222)
Michigan (159)
Minnesota (386)
Mississippi (4)
Missouri (88)
Montana (15)
Nebraska (8)
Nevada (95)
New Hampshire (58)
New Jersey (2206)
New Mexico (13)
New York (2020)
North Carolina (881)
North Dakota (3)
Northern California (4487)
Ohio (213)
Oklahoma (7)
Oregon (16)
Pennsylvania (1483)
Puerto Rico (8)
Rhode Island (20)
South America (449)
South Carolina (22)
Southern California (3466)
Tennessee (100)
Texas (1272)
United States (28701)
Utah (173)
Vermont (1)
Virginia (180)
Washington D.C. (34)
Washington State (689)
West Virginia (2)
Wisconsin (106)
261,631 Results for "4".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
Takeda’s ‘transformation program’ leaves 4,500 jobless
While Takeda is eliminating 4,500 roles across its global operations, the company has some 2,200 jobs currently open for hiring, for which internal candidates will be prioritized.
May 14, 2026
·
2 min read
·
Tristan Manalac
Press Releases
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - May 18, 2026
May 18, 2026
·
1 min read
Press Releases
4basebio Launches Enzymatic ssDNA Platform
May 11, 2026
·
3 min read
Press Releases
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 4, 2026
May 4, 2026
·
2 min read
Press Releases
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - May 4, 2026
May 4, 2026
·
1 min read
Press Releases
Zura Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - May 4, 2026
May 5, 2026
·
1 min read
Press Releases
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 4, 2026
May 4, 2026
·
2 min read
Press Releases
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 4, 2026
May 4, 2026
·
1 min read
Job Trends
Bonus Episode: Q3 2025 Job Market Update
In this bonus episode,
BioSpace’s
Vice President of Marketing Chantal Dresner and Careers Editor Angela Gabriel take a look at Q4 job market performance and what it signals for 2026.
January 19, 2026
·
1 min read
·
Angela Gabriel
Gene therapy
4 spaces primed for the next wave of gene therapies
The recent approval of Regeneron’s Otarmeni underscores the maturation of gene therapies across a range of diseases. Here,
BioSpace
reviews genetic medicines in development for the central nervous system, retinal, cardiac and neuromuscular diseases.
May 18, 2026
·
8 min read
·
Andrea Park
1 of 26,164
Next
